Grace Consulting Services Inc
General
Total Cases1
Active Cases1
Patents--
--
--
--
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
|---|---|---|
| 02/18/25 | LETTER ORDER granting [162] request for extension of the reply expert report deadline. The new deadline is 3/3/2025. Signed by Magistrate Judge Jose R. Almonte on 2/18/2025. (adc, ) (Entered: 02/18/2025) | |
| 02/14/25 | Letter from Defendants to Judge Almonte requesting an extension to the reply expert report deadline (Plaintiffs do not object). (ABRAHAM, ERIC) (Entered: 02/14/2025) | |
| 01/21/25 | TEXT ORDER: A status conference is scheduled for March 17, 2025, at 3:30 p.m. For the conference, please dial 973-437-5535 and enter Phone conference ID: 459 262 527#. No later than March 10, 2025, the parties shall file a joint letter not to exceed five (5) pages summarizing the status of the case. To the extent the parties wish to raise a discovery dispute, they shall do so consistent with the Court's [Case Management Order]. So Ordered by Magistrate Judge Jose R. Almonte on 1/21/2025. (akw, ) (Entered: 01/21/2025) | |
| 01/07/25 | ORDER granting [156] Motion to Seal. Signed by Magistrate Judge Jose R. Almonte on 1/7/2025. (adc) (Entered: 01/07/2025) | |
| 01/07/25 | NOTICE of Appearance by KRISTINE L. BUTLER on behalf of ANNORA PHARMA PRIVATE LIMITED, HETERO LABS LIMITED, HETERO USA, INC. (BUTLER, KRISTINE) (Entered: 01/07/2025) | |
| 01/07/25 | Set Deadlines as to [156] MOTION to Seal. Motion set for 2/3/2025 before Magistrate Judge Jose R. Almonte. Unless otherwise directed by the Court, this motion will be decided on the papers and no appearances are required. Note that this is an automatically generated message from the Clerk`s Office and does not supersede any previous or subsequent orders from the Court. (adc) (Entered: 01/07/2025) | |
| 01/06/25 | REDACTION to [154] Markman Response Brief,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # [1] Exhibit 39)(CHEVALIER, CHARLES) (Entered: 01/06/2025) | |
| 01/06/25 | REDACTION to [153] Response (NOT Motion),, by CATALYST PHARMACEUTICALS, INC., SERB SA. (CHEVALIER, CHARLES) (Entered: 01/06/2025) | |
| 01/06/25 | MOTION to Seal ECF Nos. 153, 154, and 154-1 by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # [1] Declaration of Charles H. Chevalier, # [2] Index, # [3] Text of Proposed Order)(CHEVALIER, CHARLES) (Entered: 01/06/2025) | |
| 12/23/24 | DECLARATION of Lauren Watt re [154] Markman Response Brief,, by CATALYST PHARMACEUTICALS, INC., SERB SA. (Attachments: # [1] Exhibit 40)(CHEVALIER, CHARLES) (Entered: 12/23/2024) |